Circulating cell-free DNA in hemodialysis patients predicts mortality

Nephrology Dialysis Transplantation

Volumn 27, Issue 10, 2012, Pages 3929-3935

  Tovbin, David ^a   Novack, Victor ^a   Wiessman, Maya Paryente ^a   Elkadir, Amir Abd ^b   Zlotnik, Moshe ^a   Douvdevani, Amos ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

cell free DNA; CFD; hemodialysis

Indexed keywords

ALBUMIN; CIRCULATING CELL FREE DNA; CREATININE; DNA; HEMOGLOBIN; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CHRONIC PATIENT; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE DURATION; DISEASE MARKER; DNA CONTENT; DNA DETERMINATION; FEMALE; FLUOROMETRY; FOLLOW UP; GENDER; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVOR; TISSUE INJURY; WEIGHT;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DNA; DNA DAMAGE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS;

EID: 84868526222     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs255     Document Type: Article

References (29)

1. Alvestrand A, Ledebo I, Hagerman I et al. Left ventricular hypertrophy in incident dialysis patients randomized to treatment with hemofiltration or hemodialysis: results from the ProFil study. Blood Purif 2011; 32: 21-29
2. Block GA, Hulbert-Shearon TE, Levin NW et al. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617
3. Degoulet P, Legrain M, Reach I et al. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron 1982; 31: 103-10
4. Lonnemann G. Chronic inflammation in hemodialysis: the role of contaminated dialysate. Blood Purif 2000; 18: 214-23
5. Panichi V, Rosati A, Bigazzi R et al. Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study. Nephrol Dial Transplant 2011; 26: 2641-8.
6. Brener ZZ, Thijssen S, Kotanko P et al. The impact of residual renal function on hospitalization and mortality in incident hemodialysis patients. Blood Purif 2011; 31: 243-51
7. Honda H, Qureshi AR, Heimburger O et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-48
8. Jean G, Terrat JC, Vanel T et al. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant 2009; 24: 2792-6
9. Korevaar JC, van Manen JG, Dekker FW et al. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. J Am Soc Nephrol 2004; 15: 2916-22
10. Pecovnik Balon B, Knehtl M, Bevc S et al. Fetuin-A as a risk factor for mortality in hemodialysis patients. Wien Klin Wochenschr 2010; 122(Suppl 2): 63-7
11. Pecovnik-Balon B, Jakopin E, Bevc S et al. Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients. Ther Apher Dial 2009; 13: 268-72
12. Seiler S, Heine GH, Fliser D. Clinical relevance of FGF-23 in chronic kidney disease. Kidney Int Suppl 2009; 76: S34-S42.
13. Stenvinkel P, Lindholm B. C-reactive protein in end-stage renal disease: are there reasons to measure it? Blood Purif 2005; 23: 72-8
14. Butt AN, Swaminathan R. Overview of circulating nucleic acids in plasma/serum. Ann N Y Acad Sci 2008; 1137: 236-42
15. Garcia Moreira V, de la Cera Martinez T, Gago Gonzalez E et al. Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR. Clin Chem Lab Med 2006; 44: 1410-5
16. Goldshtein H, Hausmann MJ, Douvdevani A. A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids. Ann Clin Biochem 2009; 46(Pt 6): 488-94
17. Boyko M, Ohayon S, Goldsmith T et al. Cell-free DNA-a marker to predict ischemic brain damage in a rat stroke experimental model. J Neurosurg Anesthesiol 2011; 23: 222-8.
18. Czeiger D, Shaked G, Eini H et al. Measurement of circulating cellfree DNA levels by a new simple fluorescent test in patients with primary colorectal cancer. Am J Clin Pathol 2011; 135: 264-70
19. Shimony A, Zahger D, Gilutz H et al. Cell free DNA detected by a novel method in acute ST-elevation myocardial infarction patients. Acute Card Care 2010; 12: 109-11
20. Vekic J, Zeljkovic A, Bogavac-Stanojevic N et al. Cox proportional hazard model analysis of survival in end-stage renal disease patients with small-sized high-density lipoprotein particles. Clin Biochem 2011; 44: 635-41
21. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer-a survey. Biochim Biophys Acta 2007; 1775: 181-232
22. Panichi V, Maggiore U, Taccola D et al. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1154-60
23. Beddhu S, Samore MH, Roberts MS et al. Creatinine production, nutrition, and glomerular filtration rate estimation. J Am Soc Nephrol 2003; 14: 1000-5
24. Korabecna M, Opatrna S, Wirth J et al. Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease. Ann N Y Acad Sci 2008; 1137: 296-301
25. Opatrna S, Wirth J, Korabecna M et al. Cell-free plasma DNA during Hemodialysis. Ren Fail 2009; 31: 475-80
26. Morena M, Delbosc S, Dupuy AM et al. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int 2005; 9: 37-46
27. Cheung AK. Biocompatibility of hemodialysis membranes. J Am Soc Nephrol 1990; 1: 150-61
28. Cottone S, Lorito MC, Riccobene R et al. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 2008; 21: 175-9
29. Tovbin D, Mazor D, Vorobiov M et al. Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation. Am J Kidney Dis 2002; 40: 1005-12